Cell Line Development Market From Research to Production: High Demand Drives Cell Line Development Market

Cell Line Development Market worth $2,537.7 Mn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell Line Development Market - (By Source of Cell Lines (Mammalian, Microbial, Insect, Others), By Application (Research and Development, Drug Development, By Company Size (Very Large and Large, Mid-sized, Small)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Cell Line Development Market is valued at US$ 1,041.3 Mn in 2023, and it is expected to reach US$ 2,537.7 Mn by 2031, with a CAGR of 11.7% during the forecast period of 2024-2031.

Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/2306

The process of using the cellular machinery to produce therapeutic biologics or other interesting proteins is known as cell line development. A cell line is a well-characterized cell culture where cells proliferate under proper growth and storage conditions. Cell lines provide a controlled environment for precisely modifying genetic structure, physiology, and cell architecture.

The growing biopharmaceutical industry, the increasing need for cancer treatments and monoclonal antibodies, and the rising production of biosimilars (as patents on branded medicines expire) are driving the cell line development market. The need for cell line generation increases in tandem with the growth of these sectors.

One benefit of employing human cell lines for protein manufacturing is the possibility that the resulting recombinant protein will have post-translational modifications compatible with native human proteins. Furthermore, rising R&D expenditures by biotechnology and pharmaceutical companies, along with growing acceptance of regenerative treatments, are anticipated to propel the expansion of the cell line development market throughout the forecast period.

List of Prominent Players in the Cell Line Development Market:

• Novartis
• Premas Biotech
• PromoCell
• Rentschler Biopharma SE
• Samsung Biologics
• Sartorius AG
• Selexis SA
• Vista Biologicals
• Biovian
• Charles River Laboratories
• Creative Biogene
• KBI Biopharma
• Lonza
• ProBioGen
• Syngene International
• Thermo Fisher Scientific
• WuXi Biologics
• Advanced Instruments, LLC.
• AGC Biologics
• Catalent
• Corning Inc.
• Cyagen
• Cytiva
• Eurofins
• FUJIFILM Diosynth Biotechnologies
• GenScript Biotech Corporation
• Horizon Discovery
• Imgenex
• NAEJA RGM Pharmaceuticals
• Others

Market Dynamics:

Drivers-
The utilization of cell line development equipment is increasing as R&D in the pharmaceutical and biotechnology industries increases to meet the growing need for treating various chronic diseases.

Cells are utilized as a model system in research projects to explore cell chemistry and cell biology in order to understand the interaction between cells as well as infectious agents such as bacteria and viruses. The cells are also utilized in drug testing to examine how medicines affect human cells. As a result of increased spending on healthcare research, the market is expanding.

Challenges:
The cell line development market's growth is hampered by stringent regulatory and licensing regulations, as well as the high initial expenditure required to start up a cell line culture laboratory. To preserve cell lines, research institutions and organizations must make significant investments. Cold storage equipment, laminar hoods, analytics equipment, and other items are included in this investment.

Furthermore, working with cell lines necessitates highly skilled personnel, and a lack of qualified workers is expected to limit the growth of the global cell line development market during the assessment period. As a result, the high initial and ongoing expenses of cell line production and maintenance are predicted to stymie worldwide market growth, as small-scale research laboratories and organizations find it prohibitive to acquire and research.

Regional Trends:
The North America Cell Line Development Market is expected to lead with a major market revenue share and it is projected to grow at a high CAGR in the near future. In comparison to most wealthy countries, the United States has a better healthcare infrastructure.

The presence of prominent companies in the United States is a vital factor driving the growth of the country's market research. Furthermore, US government support to accelerate research in the biotechnology and biopharmaceutical industries has increased demand for cell line development and technological advancements, and increased R&D spending has contributed to high regional growth.

Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2306

Recent Developments:

• In Dec 2023, FUJIFILM Corporation declared its intention to invest USD 200 million in two subsidiaries with the aim of substantially enhancing its global capabilities in contract development and manufacturing (CDMO) for cell therapy. The investment facilitated Fujifilm's backing of the burgeoning cell therapy sector, projected to experience an annual growth rate of 30%.

• In July 2022, Granite Bio and ProBioGen teamed up to offer GMP manufacturing and cell line creation services. A novel monoclonal antibody is Granite Bio's primary candidate for treating autoimmune and cancer diseases. DirectedLuck is a transposase.

Segmentation of Cell Line Development Market-
By Source of Cell Lines-
• Mammalian
• Microbial
• Insect
• Others
By Application-
• Research and Development
• Drug Development
By Company Size-
• Very Large and Large
• Mid-sized
• Small
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/report/cell-line-development-market-/2306

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.